Schizophrenia Research

Article	Citations
The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research	252
COVID-19, mobile health and serious mental illness	90
Language as a biomarker for psychosis: A natural language processing approach	81
Sleep and schizophrenia: From epiphenomenon to treatable causal target	71
COVID-19 lockdown in people with severe mental disorders in Spain: Do they have a specific psychological reaction compared with other mental disorders and healthy controls?	61
Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development	61
The impact of COVID-19 on individuals living with serious mental illness	58
The role of the gut microbiome in the development of schizophrenia	56
NMDA receptor hypofunction for schizophrenia revisited: Perspectives from epigenetic mechanisms	48
Schizophrenia and the retina: Towards a 2020 perspective	48
Thalamus-related anomalies as candidate mechanism-based biomarkers for psychosis	45
Genome-wide association studies in schizophrenia: Recent advances, challenges and future perspective	45
A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk	44
Cognitive biases in individuals with psychotic-like experiences: A systematic review and a meta-analysis	41
A Genetics Perspective on the Role of the (Neuro)Immune System in Schizophrenia	40
Relationships between psychiatric symptoms, functioning and personal recovery in psychosis	40
A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis	40
Changes of psychotic-like experiences and their association with anxiety/depression among young adolescents before COVID-19 and after the lockdown in China	40
Meta-analysis of cytokine and C-reactive protein levels in high-risk psychosis	39
Gut microbiome in serious mental illnesses: A systematic review and critical evaluation	38
The role of glutamate and GABA in cognitive dysfunction in schizophrenia and mood disorders – A systematic review of magnetic resonance spectroscopy studies	37
Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population	36
Lower speech connectedness linked to incidence of psychosis in people at clinical high risk	35
Neurodegenerative model of schizophrenia: Growing evidence to support a revisit	34
Everything is connected: Inference and attractors in delusions	34

Going deep into schizophrenia with artificial intelligence	33
Ambulatory digital phenotyping of blunted affect and alogia using objective facial and vocal analysis: Proof of concept	33
North American Prodrome Longitudinal Study (NAPLS 3): Methods and baseline description	33
Evidence for altered energy metabolism, increased lactate, and decreased pH in schizophrenia brain: A focused review and meta-analysis of human postmortem and magnetic resonance spectroscopy studies	32
Targeting cognition in schizophrenia through transcranial direct current stimulation: A systematic review and perspective	32
Internalized stigma among people with schizophrenia: Relationship with socio-demographic, clinical and medication-related features	31
Functional network connectivity in early-stage schizophrenia	30
Loneliness and psychotic experiences in a general population sample	30
Accelerated aging in the brain, epigenetic aging in blood, and polygenic risk for schizophrenia	30
Sleep spindle and slow wave abnormalities in schizophrenia and other psychotic disorders: Recent findings and future directions	30
Efficacy of transcranial direct current stimulation in ameliorating negative symptoms and cognitive impairments in schizophrenia: A systematic review and meta-analysis	30
Systematic review and meta-analysis of the relationship between genetic risk for schizophrenia and facial emotion recognition	30
Self-reported social functioning and social cognition in schizophrenia and bipolar disorder: Using ecological momentary assessment to identify the origin of bias	29
A systematic review and meta-analysis of cognitive behavioural informed psychological interventions for psychiatric inpatients with psychosis	29
Antipsychotic drug use in pregnancy: A multinational study from ten countries	29
Insula functional connectivity in schizophrenia	29
Comparisons between suicide in persons with serious mental illness, other mental disorders, or no known mental illness: Results from 37 U.S. states, 2003–2017	29
The “mind” behind the “mask”: Assessing mental states and creating therapeutic alliance amidst COVID-19	29
Peripheral complement proteins in schizophrenia: A systematic review and meta-analysis of serological studies	29
The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies	29
Long-acting injectable antipsychotics treatment during COVID-19 pandemic – A new challenge	29
The three-dimensional landscape of the genome in human brain tissue unveils regulatory mechanisms leading to schizophrenia risk	28
Pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia: A systematic review and meta-analysis	28
Intrinsic brain activity of subcortical-cortical sensorimotor system and psychomotor alterations in schizophrenia and bipolar disorder: A preliminary study	28
Neighborhood-level predictors of age at onset and duration of untreated psychosis in first-episode psychotic disorders	28
Clinical high risk for psychosis in children and adolescents: A meta-analysis of transition prevalences	27
Peripheral immune markers and antipsychotic non-response in psychosis	27
Psychosocial interventions for people with schizophrenia or psychosis on minimal or no antipsychotic medication: A systematic review	27
Do Indian patients with schizophrenia need half the recommended clozapine dose to achieve therapeutic serum level? An exploratory study	27
Characteristics and definitions of ultra-treatment-resistant schizophrenia – A systematic review and meta-analysis	26
Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people	26
The insight paradox in schizophrenia: A meta-analysis of the relationship between clinical insight and quality of life	26
Definitions of relapse in trials comparing antipsychotic maintenance with discontinuation or reduction for schizophrenia spectrum disorders: A systematic review	26
An attachment perspective on the risk for psychosis: Clinical correlates and the predictive value of attachment patterns and mentalization	26
Treatment effects on neurometabolite levels in schizophrenia: A systematic review and meta-analysis of proton magnetic resonance spectroscopy studies	26
Toward personalized medicine in schizophrenia: Genetics and epigenetics of antipsychotic treatment	26
P50 inhibitory sensory gating in schizophrenia: analysis of recent studies	26
Relationships between cognitive event-related brain potential measures in patients at clinical high risk for psychosis	26
Resting-state functional connectivity predictors of treatment response in schizophrenia – A systematic review and meta-analysis	26
Gut microbial changes of patients with psychotic and affective disorders: A systematic review	25
Psychiatric drugs impact mitochondrial function in brain and other tissues	25
Types, prevalence and gender differences of childhood trauma in first-episode psychosis. What is the evidence that childhood trauma is related to symptoms and functional outcomes in first episode psyc	25
Psychometric properties of the 15-item positive subscale of the community assessment of psychic experiences	25
Retinal ganglion cells dysfunctions in schizophrenia patients with or without visual hallucinations	25
Emotional determinants of life-space through GPS and ecological momentary assessment in schizophrenia: What gets people out of the house?	25
Long acting injectable antipsychotic medications: Ensuring care continuity during the COVID-19 pandemic restrictions	25
Real-world implementation of precision psychiatry: Transdiagnostic risk calculator for the automatic detection of individuals at-risk of psychosis	25
Multiple overlapping dynamic patterns of the visual sensory network in schizophrenia	25
The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study	24
Targeting sleep oscillations to improve memory in schizophrenia	24

The association between schizophrenia and the immune system: Review of the evidence from unbiased ‘omic-studies’	24
Anatomical integrity within the inferior fronto-occipital fasciculus and semantic processing deficits in schizophrenia spectrum disorders	24
Systematic review of racial disparities in clozapine prescribing	24
Intermittent theta burst stimulation of cerebellar vermis enhances fronto-cerebellar resting state functional connectivity in schizophrenia with predominant negative symptoms: A randomized controlled	24
Indicated association between polygenic risk score and treatment-resistance in a naturalistic sample of patients with schizophrenia spectrum disorders	24
P300 as an index of transition to psychosis and of remission: Data from a clinical high risk for psychosis study and review of literature	24
Prolonged rather than hasty decision-making in schizophrenia using the box task. Must we rethink the jumping to conclusions account of paranoia?	24
Reward anticipation in schizophrenia: A coordinate-based meta-analysis	24
Constipation screening in people taking clozapine: A diagnostic accuracy study	23
Retinal single-layer analysis with optical coherence tomography (OCT) in schizophrenia spectrum disorder	23
Different patterns of treatment response to Cognitive-Behavioural Therapy for Insomnia (CBT-I) in psychosis	23
Progressive reconfiguration of resting-state brain networks as psychosis develops: Preliminary results from the North American Prodrome Longitudinal Study (NAPLS) consortium	23
Mapping relationships among schizophrenia, bipolar and schizoaffective disorders: A deep classification and clustering framework using fMRI time series	23
Unmask the mind! Importance of video consultations in psychiatry during COVID-19 pandemic	23
Reduced sleep spindle density in adolescent patients with early-onset schizophrenia compared to major depressive disorder and healthy controls	23
Employment and relationship outcomes in first-episode psychosis: A systematic review and meta-analysis of longitudinal studies	23
Altered diffusion in motor white matter tracts in psychosis patients with catatonia	23
Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit	23
Increased rates of respiratory disease in schizophrenia: A systematic review and meta-analysis including 619,214 individuals with schizophrenia and 52,159,551 controls	23
Are we ready for a name change for schizophrenia? A survey of multiple stakeholders	23
Area deprivation, urbanicity, severe mental illness and social drift — A population-based linkage study using routinely collected primary and secondary care data	23
A conceptualized model linking matrix metalloproteinase-9 to schizophrenia pathogenesis	23
Psychotic experiences in student population during the COVID-19 pandemic	23
Longitudinal study of inflammatory markers and psychopathology in schizophrenia	22
Gender differences in the experience of psychotic-like experiences and their associated factors: A study of adolescents from the general population	22
A network meta-analysis of psychological interventions for schizophrenia and psychosis: Impact on symptoms	22
Suicide risk in young people at Ultra-High Risk (UHR) of psychosis: Findings from a 2-year longitudinal study	22
Adverse childhood experiences and psychotic-like experiences are associated above and beyond shared correlates: Findings from the adolescent brain cognitive development study	22
Cognitive remediation plus standard treatment versus standard treatment alone for individuals at ultra-high risk of developing psychosis: Results of the FOCUS randomised clinical trial	22
Clarifying the direction of impact of negative symptoms and neurocognition on prospective work functioning in psychosis: A 20-year longitudinal study	22
Changes in psychotic-like experiences and related influential factors in technical secondary school and college students during COVID-19	22
Structural and diffusion MRI based schizophrenia classification using 2D pretrained and 3D naive Convolutional Neural Networks	22
A phase 3, multicenter study to assess the 1-year safety and tolerability of a combination of olanzapine and samidorphan in patients with schizophrenia: Results from the ENLIGHTEN-2 long-term extensio	21
Evidence of reward system dysfunction in youth at clinical high-risk for psychosis from two event-related fMRI paradigms	21
Risk of diabetic complications and subsequent mortality among individuals with schizophrenia and diabetes - a population-based register study	21
Retinal function anomalies in young offspring at genetic risk of schizophrenia and mood disorder: The meaning for the illness pathophysiology	21
Theory of mind and schizotypy: A meta-analysis	21
Body representations and basic symptoms in schizophrenia	21
Prolactin levels influenced by antipsychotic drugs in schizophrenia: A systematic review and network meta-analysis	21
Prenatal infection and schizophrenia: A decade of further progress	21
The promise of layer-specific neuroimaging for testing predictive coding theories of psychosis	21
How continuum beliefs can reduce stigma of schizophrenia: The role of perceived similarities	20
White matter brain aging in relationship to schizophrenia and its cognitive deficit	20
Predictors of psychosis breakthrough during 24 months of long-acting antipsychotic maintenance treatment in first episode schizophrenia	20
Predictors of suicide at time of diagnosis in schizophrenia spectrum disorder: A 20-year total population study in Ontario, Canada	20
Mindfulness-based group therapy for in-patients with schizophrenia spectrum disorders – Feasibility, acceptability, and preliminary outcomes of a rater-blinded randomized controlled trial	20
Relationship of poor insight to neurocognition, social cognition, and psychiatric symptoms in schizophrenia: A meta-analysis	20
Sleep and psychotic symptoms: An actigraphy and diary study with young adults with low and elevated psychosis proneness	20
Depressive symptoms during first episode psychosis and functional outcome: A systematic review and meta-analysis	20
Blood-based kynurenine pathway alterations in schizophrenia spectrum disorders: A meta-analysis	20
Schizophrenia: A developmental disorder with a risk of non-specific but avoidable decline	20
Unique contributions of sensory discrimination and gamma synchronization deficits to cognitive, clinical, and psychosocial functional impairments in schizophrenia	20
What is obsession? Differentiating obsessive-compulsive disorder and the schizophrenia spectrum	20
Chronic smoking and cognition in patients with schizophrenia: A meta-analysis	19
The impact of cigarette smoking on life expectancy in schizophrenia, schizoaffective disorder and bipolar affective disorder: An electronic case register cohort study	19
The oropharyngeal microbiome is altered in individuals with schizophrenia and mania	19
Cognitive motor impairments and brain structure in schizophrenia spectrum disorder patients with a history of catatonia	19
The alliance-outcome relationship in individual psychosocial treatment for schizophrenia and early psychosis: A meta-analysis	19
Altered self-recognition in patients with schizophrenia	19
rTMS and tDCS for the treatment of catatonia: A systematic review	19
Construct validity for computational linguistic metrics in individuals at clinical risk for psychosis: Associations with clinical ratings	19
Experiential negative symptoms are more predictive of real-life functional outcome than expressive negative symptoms in clinical high-risk states	18
Beyond the cognitive insight paradox: Self-reflectivity moderates the relationship between depressive symptoms and general psychological distress in psychosis	18
Markers of glutamate and GABA neurotransmission in the prefrontal cortex of schizophrenia subjects: Disease effects differ across anatomical levels of resolution	18
Modeling perception and behavior in individuals at clinical high risk for psychosis: Support for the predictive processing framework	18
Candidate metabolic biomarkers for schizophrenia in CNS and periphery: Do any possible associations exist?	18
Differentiating patients with schizophrenia from healthy controls by hippocampal subfields using radiomics	18
Overconfidence in social cognitive decision making: Correlations with social cognitive and neurocognitive performance in participants with schizophrenia and healthy individuals	18
Subclinical schizotypal vs. autistic traits show overlapping and diametrically opposed facets in a non-clinical population	18
Advanced paternal age and risk of schizophrenia in offspring – Review of epidemiological findings and potential mechanisms	18
Social exclusion and rejection across the psychosis spectrum: A systematic review of empirical research	18
Rethinking delusions: A selective review of delusion research through a computational lens	18
Sleep disturbances and the At Risk Mental State: A systematic review and meta-analysis	18
Intervention strategies for ultra-high risk for psychosis: Progress in delaying the onset and reducing the impact of first-episode psychosis	18
Antipsychotic treatment strategies for acute phase and treatment resistance in schizophrenia: A systematic review of the guidelines and algorithms	17
Telephonic monitoring of patients on clozapine in the resource-poor setting during the COVID-19 pandemic	17
Factor analyses of multidimensional symptoms in a large group of patients with major depressive disorder, bipolar disorder, schizoaffective disorder and schizophrenia	17
An investigation of retinal layer thicknesses in unaffected first-degree relatives of schizophrenia patients	17
Changes in social functioning over the course of psychotic disorders–A meta-analysis	17
Dynamic causal modeling of eye gaze processing in schizophrenia	17

Cognitive dysfunction in a psychotropic medication-naïve, clinical high-risk sample from the ShangHai-At-Risk-for-Psychosis (SHARP) study: Associations with clinical outcomes	17
Childhood inflammatory markers and risks for psychosis and depression at age 24: Examination of temporality and specificity of association in a population-based prospective birth cohort	17
Prevalence of N-Methyl-d-Aspartate Receptor antibody (NMDAR-Ab) encephalitis in patients with first episode psychosis and treatment resistant schizophrenia on clozapine, a population based study	16
Altered structural connectivity and cytokine levels in Schizophrenia and Genetic high-risk individuals: Associations with disease states and vulnerability	16
A systematic review of suicide and suicide attempts in adolescents with psychotic disorders	16
Gender differences in the association between environment and psychosis	16
Schizophrenia patients and their healthy siblings share decreased prefronto-thalamic connectivity but not increased sensorimotor-thalamic connectivity	16
Neuromodulation of sleep rhythms in schizophrenia: Towards the rational design of non-invasive brain stimulation	16
First episode psychosis following receipt of first dose of COVID-19 vaccine: A case report	16
Gender disparities in clozapine prescription in a cohort of treatment-resistant schizophrenia in the South London and Maudsley case register	16
Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder	16
Suicidal thoughts and behavior (STB) and psychosis-risk symptoms among psychiatrically hospitalized adolescents	16
Ten-year trajectory and outcomes of negative symptoms of patients with first-episode schizophrenia spectrum disorders	16
Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness	15
A meta-analysis of the relationship between psychosis and any type of criminal offending, in both men and women	15
Examining which factors influence age of onset in males and females with schizophrenia	15
Safety and tolerability of lumateperone 42 mg: An open-label antipsychotic switch study in outpatients with stable schizophrenia	15
Longitudinal symptom changes and association with home time in people with schizophrenia: An observational digital phenotyping study	15
Optical coherence tomography of the retina in schizophrenia: Inter-device agreement and relations with perceptual function	15
“I just don't look forward to anything”. How anticipatory pleasure and negative beliefs contribute to goal-directed activity in patients with negative symptoms of psychosis	15
Impact of childhood trauma on positive and negative symptom remission in first episode psychosis	15
Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study	15
Functional impairment of cortical AMPA receptors in schizophrenia	15
A meta-analysis of social cognitive deficits in schizophrenia: Does world region matter?	15
The relationship between childhood abuse and severity of psychosis is mediated by loneliness: an experience sampling study	15
Choline, folic acid, Vitamin D, and fetal brain development in the psychosis spectrum	15
Chronic fatigue and fibromyalgia symptoms are key components of deficit schizophrenia and are strongly associated with activated immune-inflammatory pathways	15
Ultrastructural evidence for glutamatergic dysregulation in schizophrenia	15
Transcriptomic abnormalities in peripheral blood in bipolar disorder, and discrimination of the major psychoses	15
The proteome and its dynamics: A missing piece for integrative multi-omics in schizophrenia	15
Reinforcement learning as an intermediate phenotype in psychosis? Deficits sensitive to illness stage but not associated with polygenic risk of schizophrenia in the general population	15
Face pareidolia in schizophrenia	15
Current psychotic-like experiences among adolescents in China: Identifying risk and protective factors	14
Sleep spindle activity in childhood onset schizophrenia: Diminished and associated with clinical symptoms	14
Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings	14
Suicidal ideation in first-episode psychosis: Considerations for depression, positive symptoms, clinical insight, and cognition	14
Healthcare costs and resource use associated with negative symptoms of schizophrenia: A systematic literature review	14
Lower functional connectivity of white matter during rest and working memory tasks is associated with cognitive impairments in schizophrenia	14
Speech disturbances in schizophrenia: Assessing cross-linguistic generalizability of NLP automated measures of coherence	14
A symptom combination predicting treatment-resistant schizophrenia – A strategy for real-world clinical practice	14
Criterion validity of the Psychotic-Like Experiences Questionnaire for Children (PLEQ-C)	14
Interoceptive functioning in schizophrenia and schizotypy	14
Aberrant posterior cingulate connectivity classify first-episode schizophrenia from controls: A machine learning study	14
Adult outcome of preterm birth: Implications for neurodevelopmental theories of psychosis	14
Structural covariance networks in schizophrenia: A systematic review Part I	14
Coronovirus infection as a novel delusional topic	14
Association of schizophrenia polygenic risk score with data-driven cognitive subtypes: A six-year longitudinal study in patients, siblings and controls	14
Neurodevelopmental concepts of schizophrenia in the genome-wide association era: AKT/mTOR signaling as a pathological mediator of genetic and environmental programming during development	14
Risk of dementia and death in very-late-onset schizophrenia-like psychosis: A national cohort study	14
Incorporating cortisol into the NAPLS2 individualized risk calculator for prediction of psychosis	14
Gene expression meta-analysis reveals the down-regulation of three GABA receptor subunits in the superior temporal gyrus of patients with schizophrenia	14
Motivational theory-based interventions on health of people with several mental illness: A systematic review and meta-analysis	13
Spatial localization of retinal anomalies in regular cannabis users: The relevance of the multifocal electroretinogram	13
Reinventing schizophrenia. Updating the construct	13
Effects of risperidone monotherapy on the default-mode network in antipsychotic-naïve first-episode schizophrenia: Posteromedial cortex heterogeneity and relationship with the symptom improvements	13
Renaming schizophrenia? A survey among psychiatrists, mental health service users and family members in Italy	13
Group mindfulness-based therapy for persecutory delusions: A pilot randomised controlled trial	13
Decreased cardiovascular death in schizophrenia patients treated with antipsychotics: A Korean national cohort study	13
Copy number variations of satellite III (1q12) and ribosomal repeats in health and schizophrenia	13
Loneliness and its association with health service utilization in people with a psychotic disorder	13
Investigating the diagnostic utility of speech patterns in schizophrenia and their symptom associations	13
Add on yoga treatment for negative symptoms of schizophrenia: A multi-centric, randomized controlled trial	13
Sensorimotor conflicts induce somatic passivity and louden quiet voices in healthy listeners	13
A single psychotomimetic dose of ketamine decreases thalamocortical spindles and delta oscillations in the sedated rat	13
Molecular alterations in the medial temporal lobe in schizophrenia	13
The relationship between appraisals of voices (auditory verbal hallucinations) and distress in voice-hearers with schizophrenia-spectrum diagnoses: A meta-analytic review	13
Complement C4 associations with altered microbial biomarkers exemplify gene-by-environment interactions in schizophrenia	13
Cortical gray matter reduction precedes transition to psychosis in individuals at clinical high-risk for psychosis: A voxel-based meta-analysis	13
Profile of cognitive deficits in schizophrenia and factor structure of the Czech MATRICS Consensus Cognitive Battery	13
Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia	13
Transcriptome analysis of human induced excitatory neurons supports a strong effect of clozapine on cholesterol biosynthesis	13
Virtual reality based cognitive behavioral therapy for paranoia: Effects on mental states and the dynamics among them	13
Neurobiological underpinnings of cognitive subtypes in psychoses: A cross-diagnostic cluster analysis	13
The glutamate/N-methyl-d-aspartate receptor (NMDAR) model of schizophrenia at 35: On the path from syndrome to disease	12
Clozapine treated patients and COVID-19: Ensuring continued care through collaboration	12
Persistent cannabis use among young adults with early psychosis receiving coordinated specialty care in the United States	12
Social decline in the psychosis prodrome: Predictor potential and heterogeneity of outcome	12
Thalamic and striato-pallidal volumes in schizophrenia patients and individuals at risk for psychosis: A multi-atlas segmentation study	12
Infections, antibiotic treatment and the Microbiome in relation to schizophrenia	12
Could CRP be a differential biomarker of illness stages in schizophrenia? A systematic review and meta-analysis	12
Grey-matter abnormalities in clinical high-risk participants for psychosis	12
Molecular signaling pathways underlying schizophrenia	12
Schizophrenia in the flesh: Revisiting schizophrenia as a disorder of the bodily self	12
Mortality and non-use of antipsychotic drugs after acute admission in schizophrenia: A prospective total-cohort study	12
Deep learning model using retinal vascular images for classifying schizophrenia	12
Induced ideas of reference during social unrest and pandemic in Hong Kong	12
Neuroplasticity and inflammatory alterations in the nucleus accumbens are corrected after risperidone treatment in a schizophrenia-related developmental model in rats	12
Sleep disturbances in schizophrenia and psychosis	12
Longitudinal relationships between mismatch negativity, cognitive performance, and real-world functioning in early psychosis	12
Randomized controlled trial of an adjunctive sulforaphane nutraceutical in schizophrenia	12
Clinical, behavioural and neural validation of the PANSS amotivation factor	12
Exposure to Epstein Barr virus and cognitive functioning in individuals with schizophrenia	12
Ensuring care for clozapine-treated schizophrenia patients during the COVID-19 pandemic	12
Exploring indigenous ethnic inequities in first episode psychosis in New Zealand – A national cohort study	12
Triple network hypothesis-related disrupted connections in schizophrenia: A spectral dynamic causal modeling analysis with functional magnetic resonance imaging	12